Drugs / A+C Vaccine
last change Jan 2012 re-read 2 minutes ago

A+C Vaccine

Vaccine

Developed for
meningococcemia

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01428908 Comparator Sep → Dec 2011 haemophilus infectious disease, meningococcemia Jiangsu Province Centers for Disease Control and Prevention Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as A+C Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01428908
Modality Vaccine “The group A, C polysaccharide meningococcal vaccineNCT01428908
Route Intramuscular “will be administered intramuscularly on one arm” NCT01428908